The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
Open accessAbstract
CONTEXT: Sickle cell disease is characterized by a state of nitric oxide resistance and limited bioavailability of l-arginine, the substrate for nitric oxide synthesis. We hypothesized that increased arginase activity and dysregulated arginine metabolism contribute to endothelial dysfunction, pulmonary hypertension, and patient outcomes. OBJECTIVE: To explore the role of arginase in sickle cell disease pathogenesis, pulmonary hypertension, and mortality. DESIGN: Plasma amino acid levels, plasma and erythrocyte arginase activities, and pulmonary hypertension status as measured by Doppler echocardiogram were prospectively obtained in outpatients with sickle cell disease. Patients were followed up for survival up to 49 months. SETTING: Urban tertiary care center and community clinics in the United States between February 2001 and March 2005. PARTICIPANTS: Two hundred twenty-eight patients with sickle cell disease, aged 18 to 74 years, and 36 control participants. MAIN OUTCOME MEASURES: Plasma amino acid levels, plasma and erythrocyte arginase activities, diagnosis of pulmonary hypertension, and mortality. RESULTS: Plasma arginase activity was significantly elevated in patients with sickle cell disease, with highest activity found in patients with secondary pulmonary hypertension. Arginase activity correlated with the arginine-ornithine ratio, and lower ratios were associated with greater severity of pulmonary hypertension and with mortality in this population (risk ratio, 2.5; 95% confidence interval [CI], 1.2-5.2; P = .006). Global arginine bioavailability, characterized by the ratio of arginine to ornithine plus citrulline, was also strongly associated with mortality (risk ratio, 3.6; 95% CI, 1.5-8.3; P<.001). Increased plasma arginase activity was correlated with increased intravascular hemolytic rate and, to a lesser extent, with markers of inflammation and soluble adhesion molecule levels. CONCLUSIONS: These data support a novel mechanism of disease in which hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide. The ratios of arginine to ornithine and arginine to ornithine plus citrulline are independently associated with pulmonary hypertension and increased mortality in patients with sickle cell disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Hosmer, D. W., Lemeshow, S. A., & May, S. J. (2008) · Cited by 3,030
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
R EGULATION OF E NZYMES OF THE U REA C YCLE AND A RGININE M ETABOLISM
Morris, S. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.110801.140547 · Cited by 725
Xia, Y., Dawson, V. L., Dawson, T. M., Snyder, S. H., & Zweier, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6770 · Cited by 718
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
Circulating Activated Endothelial Cells in Sickle Cell Anemia
Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E., & Hebbel, R. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372203 · Cited by 628
Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase
Heinzel, B., John, M., Klatt, P., Böhme, E., & Mayer, B. (1992) · Biochemical Journal · doi:10.1042/bj2810627 · Cited by 530
Zimmermann, N., King, N. E., Laporte, J., Yang, M., Mishra, A., Pope, S. M., Muntel, E. E., Witte, D. P., Pegg, A. A., Foster, P. S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17912 · Cited by 488
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
HEBBEL, R. P., OSAROGIAGBON, R., & KAUL, D. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 463
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391
Xu, W., Kaneko, F. T., Zheng, S., Comhair, S. A. A., Janocha, A. J., Goggans, T., Thunnissen, F. B. J. M., Farver, C., Hazen, S. L., Jennings, C., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2317fje · Cited by 369
Regulation of Nitric Oxide Production by Arginine Metabolic Enzymes
Mori, M., & Gotoh, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3169 · Cited by 346
Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Morris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 329
Self-citationPulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
Boucher, J. L., Moali, C., & Tenu, J. P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050352 · Cited by 316
Decreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma
Morris, C. R., Poljakovic, M., Lavrisha, L., Machado, L., Kuypers, F. A., & Morris, S. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1304oc · Cited by 283
Self-citationDivergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., Schenke, W. H., Csako, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2003) · Circulation · doi:10.1161/01.cir.0000044943.12533.a8 · Cited by 273
Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells
Morris, S. M., Kepka-Lenhart, D., & Chen, L.-C. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e740 · Cited by 252
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
Matsui, N. M., Borsig, L., Rosen, S. D., Yaghmai, M., Varki, A., & Embury, S. H. (2001) · Blood · doi:10.1182/blood.v98.6.1955 · Cited by 240
KANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., & ERZURUM, S. C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9802066 · Cited by 228
Tissue factor expression by endothelial cells in sickle cell anemia.
Solovey, A., Gui, L., Key, N. S., & Hebbel, R. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1932 · Cited by 222
Jison, M. L., Munson, P. J., Barb, J. J., Suffredini, A. F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J. H., Shelhamer, J. H., Danner, R. L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2760 · Cited by 221
Morris, C. R., Kuypers, F. A., Larkin, S., Vichinsky, E. P., & Styles, L. A. (2000) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200011000-00009 · Cited by 213
Self-citationRelative importance of kidney and liver in synthesis of arginine by the rat
Featherston, W., Rogers, Q., & Freedland, R. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.1.127 · Cited by 187
Pulmonary hypertension in sickle cell disease
Sutton, L. L., Castro, O., Cross, D. J., Spencer, J. E., & Lewis, J. F. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90760-9 · Cited by 184
Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness
Meurs, H., Maarsingh, H., & Zaagsma, J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00227-x · Cited by 178
Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension
Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D. (1995) · Circulation · doi:10.1161/01.cir.92.6.1539 · Cited by 177
Prevalence and reversibility of lower airway obstruction in children with sickle cell disease
Koumbourlis, A. C., Zar, H. J., Hurlet-Jensen, A., & Goldberg, M. R. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111824 · Cited by 174
Biological activity of nitric oxide in the plasmatic compartment
Wang, X., Tanus-Santos, J. E., Reiter, C. D., Dejam, A., Shiva, S., Smith, R. D., Hogg, N., & Gladwin, M. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402201101 · Cited by 164
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy
Reiter, C. D., & Gladwin, M. T. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200303000-00001 · Cited by 159
Meurs, H., McKay, S., Maarsingh, H., Hamer, M. A. M., Macic, L., Molendijk, N., & Zaagsma, J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704725 · Cited by 155
Role of Nitric Oxide in the Local Regulation of Pulmonary Vascular Resistance in Humans
Cooper, C. J., Landzberg, M. J., Anderson, T. J., Charbonneau, F., Creager, M. A., Ganz, P., & Selwyn, A. P. (1996) · Circulation · doi:10.1161/01.cir.93.2.266 · Cited by 154
Embury, S. H. (2004) · Blood · doi:10.1182/blood-2004-02-0713 · Cited by 141
Airway hyperreactivity in children with sickle cell disease
Leong, M. A., Dampier, C., Varlotta, L., & Allen, J. L. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70166-5 · Cited by 140
Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease
Morris, C. R., Kuypers, F. A., Larkin, S. K., Sweeters, N., Simon, J., Vichinsky, E. P., & Styles, L. A. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02403.x · Cited by 126
Self-citationImpaired nitric oxide-mediated vasodilation in transgenic sickle mouse
Kaul, D. K., Liu, X.-D., Fabry, M. E., & Nagel, R. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1799 · Cited by 122
Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension
Archer, S. L., Djaballah, K., Humbert, M. J. C., Weir, Ε. K., Fartoukh, M. S., DALL'AVA-SANTUCCI, J., Mercier, J., Simonneau, G., & Dinh‐Xuan, A. T. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9802113 · Cited by 112
Pulmonary Hypertension and Right Heart Failure in Patients With β-Thalassemia Intermedia
Aessopos, A., Stamatelos, G., Skoumas, V., Vassilopoulos, G., Mantzourani, M., & Loukopoulos, D. (1995) · CHEST Journal · doi:10.1378/chest.107.1.50 · Cited by 109
Cytokines in Sickle Cell Disease
Pathare, A. V., Alkindi, S. S. A., Daar, S., & Dennison, D. (2003) · Hematology · doi:10.1080/10245330310001604719 · Cited by 109
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
Kaul, D. K., Liu, X.-D., Chang, H.-Y., Nagel, R. L., & Fabry, M. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21633 · Cited by 109
Expression, regulation and function of carrier proteins for cationic amino acids
Closs, E. I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200201000-00015 · Cited by 107
Komai, M., Tanaka, H., Masuda, T., Nagao, K., Ishizaki, M., Sawada, M., & Nagai, H. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705105 · Cited by 107
Morris, C. R., Kuypers, F. A., Larkin, S. K., Sweeters, N., Simon, J., Vichinsky, E. P., & Styles, L. A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02403.x · Cited by 104
Self-citationHydroxyurea and Arginine Therapy: Impact on Nitric Oxide Production in Sickle Cell Disease
Morris, C. R., Vichinsky, E. P., van Warmerdam, J., Machado, L., Kepka‐Lenhart, D., Morris, S. M., & Kuypers, F. A. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200308000-00008 · Cited by 102
Self-citationEvidence for a metabolic shift of arginine metabolism in sickle cell disease
Schnog, J. B., Jager, E. H., van der Dijs, F. P. L., Duits, A. J., Moshage, H. J., Muskiet, F. D., & Muskiet, F. A. J. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0856-9 · Cited by 101
Regulation of lipid metabolism by cytokines during host defense
Grünfeld, C., & Feingold, K. R. (1996) · Nutrition · doi:10.1016/0899-9007(96)90013-1 · Cited by 94
Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency
Chou, R., & DeLoughery, T. G. (2001) · American Journal of Hematology · doi:10.1002/ajh.1107 · Cited by 93
Renal nitric oxide synthases in transgenic sickle cell mice
Bank, N., Aynedjian, H. S., Qiu, J.-H., Osei, S. Y., Ahima, R. S., Fabry, M. E., & Nagel, R. L. (1996) · Kidney International · doi:10.1038/ki.1996.301 · Cited by 91
Lipoprotein Remnants and Endothelial Dysfunction in the Postprandial Phase
Maggi, F. M., Raselli, S., Grigore, L., Redaelli, L., Fantappiè, S., & Catapano, A. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031977 · Cited by 86
Regulation of Arginine Availability and Its Impact on NO Synthesis
Morris, S. M. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50012-5 · Cited by 75
Dias‐da‐Motta, P. M., Arruda, V. R., Muscará, M. N., Saad, S. T. O., Nucci, G. D., Costa, F. F., & Condino‐Neto, A. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4951036.x · Cited by 70
Pulmonary Hypertension in Paroxysmal Nocturnal Hemoglobinuria
Heller, P. G., Grinberg, A. R., Lencioni, M., Molina‐Molina, M., & Roncoroni, A. J. (1992) · CHEST Journal · doi:10.1378/chest.102.2.642 · Cited by 63
Jison, M. L., & Gladwin, M. T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2304002 · Cited by 56
Marchesi, S., Lupattelli, G., Lombardini, R., Roscini, A. R., Siepi, D., Vaudo, G., Pirro, M., Sinzinger, H. F., Schillaci, G., & Mannarino, E. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.0269-4727.2003.00512.x · Cited by 49
Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship?
Verresen, D., Backer, W. D., van Meerbeeck, J. P., Neetens, I., Marck, E. V., & Vermeire, P. A. (1991) · European Respiratory Journal · doi:10.1183/09031936.93.04050629 · Cited by 46
Arginase activity in erythrocytes of healthy and ill children
Azizi, E., Dror, Y., & Wallis, K. T. (1970) · Clinica Chimica Acta · doi:10.1016/0009-8981(70)90063-x · Cited by 45
Differential Expression of E‐ and P‐Selectin in the Microvasculature of Sickle Cell Transgenic Mice
Wood, K., Russell, J., Hebbel, R. P., & Granger, D. N. (2004) · Microcirculation · doi:10.1080/10739680490437559 · Cited by 42
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Primary Pulmonary Hypertension
Stuard, I. D., Heusinkveld, R. S., & Moss, A. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871710 · Cited by 41
Th1 and Th2 Cytokine Profiles in Sickle Cell Disease
Raghupathy, R., Haider, M. Z., Azizieh, F. Y., Abdelsalam, R., D’Souza, T. M., & Adekile, A. D. (2000) · Acta Haematologica · doi:10.1159/000041049 · Cited by 39
Primary Pulmonary Hypertension
Jubelirer, S. J. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.6.1221 · Cited by 35
Mansoor, M. A., Seljeflot, I., Arnesen, H., Knudsen, A.-M., Bates, C. J., Mishra, G. D., & Larsen, T. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.01.003 · Cited by 34
Evidence that L-arginine is a key amino acid in sickle cell anemia — A preliminary report
Waugh, W. H., Daeschner, C., Files, B. A., & Gordon, D. W. (1999) · Nutrition Research · doi:10.1016/s0271-5317(99)00017-2 · Cited by 28
Renal Pathology in Hemizygous Sickle Cell Mice
Diwan, B. A., Gladwin, M. T., Noguchi, C. T., Ward, J. M., Fitzhugh, A. L., & Buzard, G. S. (2002) · Toxicologic Pathology · doi:10.1080/019262302753559597 · Cited by 18
Relationship between Arginase Activity and Nitric Oxide Production
Mori, M., & Gotoh, T. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50013-7 · Cited by 16
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510865 · Cited by 1,488
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Arginine metabolism and nutrition in growth, health and disease
Wu, G., Bazer, F. W., Davis, T. A., Kim, S. W., Li, P., Marc Rhoads, J., Carey Satterfield, M., Smith, S. B., Spencer, T. E., & Yin, Y. (2009) · Amino Acids · doi:10.1007/s00726-008-0210-y · Cited by 1,362
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Self-citation
Metadata
- Authors
- Morris, C. R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-07-06
- Volume
- 294
- Issue
- 1
- Pages
- 81
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2049292864
- Cited by
- 763
- References
- 67
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.